Want to see IN:AJOONI full AI Analyst Report?
AJOONI Stock Chart & Stats
₹5.13
₹0.07(0.90%)
At close: 4:00 PM EST
₹5.13
₹0.07(0.90%)
Day’s Range― - ―
52-Week Range₹3.40 - ₹5.94
Previous CloseN/A
Volume422.93K
Average Volume (3M)291.11K
Market Cap
₹639.02M
Enterprise Value₹897.51
Total Cash (Recent Filing)₹3.74M
Total Debt (Recent Filing)₹269.11M
Price to Earnings (P/E)16.5
Beta1.01
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding172,243,590
10 Day Avg. Volume338,623
30 Day Avg. Volume291,108
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthStrong and accelerating top-line growth indicates improving scale and market adoption across the animal health and nutrition portfolio. If sustained, higher volumes can strengthen distribution reach and create operating leverage over the next several quarters.
Conservative Balance SheetLow leverage gives Ajooni flexibility to fund inventory, distribution, and measured expansion without relying heavily on external financing. This provides resilience in a working-capital-intensive business and reduces balance-sheet risk over the medium term.
Expanded Equity BaseA larger equity base strengthens the company’s capacity to absorb operating volatility and support growth initiatives. Positive ROE shows the expanded capital base is generating returns, although improving efficiency remains important for stronger long-term value creation.
Bears Say
Persistent Negative Operating Cash FlowRepeated operating cash losses indicate that reported earnings are not converting reliably into cash, potentially because of working-capital needs or investment requirements. Persistent weak conversion can constrain self-funded growth and increase reliance on financing.
Deepening Free Cash Flow DeficitA worsening free-cash-flow deficit raises funding and execution risk even while revenue grows. Unless working-capital discipline, capital spending, or operating cash generation improves, expansion may consume liquidity and limit the company’s ability to scale sustainably.
Thin And Softening MarginsLow and declining margins leave limited protection against raw-material, manufacturing, or distribution-cost pressure. Thin profitability also reduces the benefit of strong sales growth and makes earnings more vulnerable if pricing, product mix, or operating costs deteriorate.
Ajooni Biotech Limited News
AJOONI FAQ
What was Ajooni Biotech Limited’s price range in the past 12 months?
Ajooni Biotech Limited lowest stock price was ₹3.40 and its highest was ₹5.94 in the past 12 months.
What is Ajooni Biotech Limited’s market cap?
Ajooni Biotech Limited’s market cap is ₹639.02M.
When is Ajooni Biotech Limited’s upcoming earnings report date?
Ajooni Biotech Limited’s upcoming earnings report date is Nov 06, 2026 which is in 62 days.
How were Ajooni Biotech Limited’s earnings last quarter?
Ajooni Biotech Limited released its earnings results on Aug 14, 2026. The company reported ₹0.025 earnings per share for the quarter.
Is Ajooni Biotech Limited overvalued?
According to Wall Street analysts Ajooni Biotech Limited’s price is currently Overvalued.
Does Ajooni Biotech Limited pay dividends?
Ajooni Biotech Limited does not currently pay dividends.
What is Ajooni Biotech Limited’s EPS estimate?
Ajooni Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ajooni Biotech Limited have?
Ajooni Biotech Limited has 172,243,590 shares outstanding.
What happened to Ajooni Biotech Limited’s price movement after its last earnings report?
Ajooni Biotech Limited reported an EPS of ₹0.025 in its last earnings report. Following the earnings report the stock price went up 2.387%.
Which hedge fund is a major shareholder of Ajooni Biotech Limited?
Currently, no hedge funds are holding shares in IN:AJOONI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ajooni Biotech Limited
Founded in 2010, Ajooni Biotech Limited is an Indian enterprise primarily engaged in the production and distribution of animal nutrition products. Headquartered in Mohali, India, the company's offerings encompass specialized cattle feeds and various dietary supplements for livestock.
Technical Analysis
Avanti Feeds Limited
―
M K Proteins Limited
―
Mukka Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―